AAAAAA

   
Results: 1-12 |
Results: 12
A new quinoline derivative MS-209 reverses multidrug resistance and inhibits multiorgan metastases by P-glycoprotein-expressing human small cell lungcancer cells
Authors: Nokihara, H Yano, S Nishioka, Y Hanibuchi, M Higasida, T Tsuruo, T Sone, S
Citation: H. Nokihara et al., A new quinoline derivative MS-209 reverses multidrug resistance and inhibits multiorgan metastases by P-glycoprotein-expressing human small cell lungcancer cells, JPN J CANC, 92(7), 2001, pp. 785-792
Humanized anti-ganglioside GM2 antibody is effective to induce antibody-dependent cell-mediated cytotoxicity in mononuclear cells from lung cancer patients
Authors: Parajuli, P Yanagawa, H Hanibuchi, M Takeuchi, E Miki, T Yano, S Sone, S
Citation: P. Parajuli et al., Humanized anti-ganglioside GM2 antibody is effective to induce antibody-dependent cell-mediated cytotoxicity in mononuclear cells from lung cancer patients, CANCER LETT, 165(2), 2001, pp. 179-184
Immunological circumvention of multiple organ metastases of multidrug resistant human small cell lung cancer cells by mouse-human chimeric anti-ganglioside GM2 antibody KM966
Authors: Hanibuchi, M Yano, S Nishioka, Y Yanagawa, H Miki, T Sone, S
Citation: M. Hanibuchi et al., Immunological circumvention of multiple organ metastases of multidrug resistant human small cell lung cancer cells by mouse-human chimeric anti-ganglioside GM2 antibody KM966, CLIN EXP M, 18(5), 2001, pp. 353-360
Bone metastasis model with multiorgan dissemination of human small-cell lung cancer (SBC-5) cells in natural killer cell-depleted SCID mice
Authors: Miki, T Yano, S Hanibuchi, M Sone, S
Citation: T. Miki et al., Bone metastasis model with multiorgan dissemination of human small-cell lung cancer (SBC-5) cells in natural killer cell-depleted SCID mice, ONCOL RES, 12(5), 2000, pp. 209-217
Human interferon-gamma enhances expression of ganglioside GM2 on human lung cancer cells and their susceptibility for antiganglioside GM2 monoclonal antibody-dependent cellular cytotoxicity
Authors: Hanibuchi, M Nishioka, Y Yanagawa, H Yano, S Parajuli, P Bando, M Sone, S
Citation: M. Hanibuchi et al., Human interferon-gamma enhances expression of ganglioside GM2 on human lung cancer cells and their susceptibility for antiganglioside GM2 monoclonal antibody-dependent cellular cytotoxicity, ONCOL RES, 12(4), 2000, pp. 173-179
Augmentation by interleukin-18 of MHC-nonrestricted killer activity of human peripheral blood mononuclear cells in response to interleukin-12
Authors: Singh, SM Yanagawa, H Hanibuchi, M Miki, T Okamura, H Sone, S
Citation: Sm. Singh et al., Augmentation by interleukin-18 of MHC-nonrestricted killer activity of human peripheral blood mononuclear cells in response to interleukin-12, INT J IMMUN, 22(1), 2000, pp. 35-43
Therapeutic efficacy of a new topoisomerase I and II inhibitor TAS-103, against both P-glycoprotein-expressing and -nonexpressing drug-resistant human small-cell lung cancer
Authors: Parajuli, P Yano, S Nishioka, Y Nokihara, H Hanibuchi, M Nishimura, N Utsugi, T Sone, S
Citation: P. Parajuli et al., Therapeutic efficacy of a new topoisomerase I and II inhibitor TAS-103, against both P-glycoprotein-expressing and -nonexpressing drug-resistant human small-cell lung cancer, ONCOL RES, 11(5), 1999, pp. 219-224
Production of interleukin-10 by alveolar macrophages from lung cancer patients
Authors: Yanagawa, H Takeuchi, E Suzuki, Y Hanibuchi, M Haku, T Ohmoto, Y Sone, S
Citation: H. Yanagawa et al., Production of interleukin-10 by alveolar macrophages from lung cancer patients, RESP MED, 93(9), 1999, pp. 666-671
Cytolysis of human dendritic cells by autologous lymphokine-activated killer cells: participation of both T cells and NK cells in the killing
Authors: Parajuli, P Nishioka, Y Nishimura, N Singh, SM Hanibuchi, M Nokihara, H Yanagawa, H Sone, S
Citation: P. Parajuli et al., Cytolysis of human dendritic cells by autologous lymphokine-activated killer cells: participation of both T cells and NK cells in the killing, J LEUK BIOL, 65(6), 1999, pp. 764-770
Heterogeneity of multiorgan metastases of human lung cancer cells genetically engineered to produce cytokines and reversal using chimeric monoclonal antibodies in natural killer cell-depleted severe combined immunodeficient mice
Authors: Sone, S Yano, S Hanibuchi, M Nokihara, H Nishimura, N Miki, T Nishioka, Y Shinohara, T
Citation: S. Sone et al., Heterogeneity of multiorgan metastases of human lung cancer cells genetically engineered to produce cytokines and reversal using chimeric monoclonal antibodies in natural killer cell-depleted severe combined immunodeficient mice, CANC CHEMOT, 43, 1999, pp. S26-S31
Combined therapy with anti-P-glycoprotein antibody and macrophage colony-stimulating factor gene transduction for multiorgan metastases of multidrug-resistant human small cell lung cancer in NK cell-depleted scid
Authors: Yano, S Hanibuchi, M Nishioka, Y Nokihara, H Nishimura, N Tsuruo, T Sone, S
Citation: S. Yano et al., Combined therapy with anti-P-glycoprotein antibody and macrophage colony-stimulating factor gene transduction for multiorgan metastases of multidrug-resistant human small cell lung cancer in NK cell-depleted scid, INT J CANC, 82(1), 1999, pp. 105-111
Apoptosis induction of human lung cancer cell line in multicellular heterospheroids with humanized antiganglioside GM2 monoclonal antibody
Authors: Nakamura, K Hanibuchi, M Yano, S Tanaka, Y Fujino, I Inoue, M Takezawa, T Shitara, K Sone, S Hanai, N
Citation: K. Nakamura et al., Apoptosis induction of human lung cancer cell line in multicellular heterospheroids with humanized antiganglioside GM2 monoclonal antibody, CANCER RES, 59(20), 1999, pp. 5323-5330
Risultati: 1-12 |